text: <unk>  is an antineoplastic agent that is FDA approved for the treatment of relapsed chronic lymphocytic leukemia,  relapsed follicular b-cell non-hodgkin lymphoma and relapsed small lymphocytic lymphoma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hyperglycemia, hypertriglyceridemia, abdominal pain, nausea, neutropenia, cough, fatigue, fever and shivering.
option_0: Idelalisib
option_1: Duvelisib
option_2: Alpelisib
option_3: Glasdegib
option_4: Enasidenib
option_5: Vismodegib
option_6: Evacetrapib
option_7: Ivosidenib